Skip to main content
CRTonline Podcast

CRTonline Podcast

By CRTonline Podcast
CRTonline Podcast is a collection of interviews with well renowned physicians on medical journals and on-going issues around the world of medicine.
Where to listen
Castbox Logo

Castbox

Google Podcasts Logo

Google Podcasts

Overcast Logo

Overcast

Pocket Casts Logo

Pocket Casts

RadioPublic Logo

RadioPublic

Spotify Logo

Spotify

The King and I: Season3 | Episode 05 | What is the controversy with the guidelines for chest pain diagnosis?
Ron Waksman, Spencer B. King, III
33:47
July 29, 2022
CRM Journal Club | Revascularization or Optimal Medical Therapy for Stable Ischemic Heart Disease: A Bayesian Meta-Analysis of Contemporary Trials
Ron Waksman, MD; Spencer B. King, III, MD; Gary S. Mintz, MD; and Ashish Kumar, MD
22:49
July 15, 2022
CRM Journal Club | Expansion of Insurance Under the Affordable Care Act and Invasive Management of Acute Myocardial Infarction
Ron Waksman, MD; Spencer B. King, III, MD; Gary S. Mintz, MD; and Jason H. Wasfy, MD
25:03
June 27, 2022
The King and I: Season3 | Episode 02 | Guns in hospitals and gun control
Ron Waksman, Spencer B. King, III
29:58
June 15, 2022
CRM Journal Club | Racial and Ethnic Disparities in the Use of Transcatheter Aortic Valve Replacement in the State of Connecticut
Ron Waksman, MD; Spencer B. King, III, MD; Gary S. Mintz, MD; and Abdelrahman Ali, MD
28:49
April 21, 2022
CRM Journal Club | Association Between Hospital Cardiovascular Procedural Volumes and Transcatheter Mitral Valve Repair Outcomes
Ron Waksman, MD; Spencer B. King, III, MD; Gary S. Mintz, MD; and Sammy Elmariah, MD, MPH
24:29
March 24, 2022
CRM Journal Club | First-in-Man Evaluation of a Sirolimus-Eluting Stent With Abluminal Fluoropolymeric/Triflusal Coating With Ultrathin Struts by OCT at 9 Months' Follow-Up: The PROMETHEUS Study
Jose M. de la Torre Hernandez, MD, PhD; Imanol Otaegui, MD; Asier Subinas, MD, PhD; Antonio Gomez-Menchero, MD, PhD; Raul Moreno, MD, PhD; Juan Rondan, MD, PhD; Erika Munoz-Garcia, MD; Fermin Sainz-La
27:43
November 29, 2021
The King and I: Season2, Episode 16 | Colin Powell and Outpatient PCI
Ron Waksman, Spencer B. King, III
13:25
November 02, 2021
CRM Journal Club | Percutaneous Versus Surgical Revascularization for Acute Myocardial Infarction
Tariq Enezate, MD; Kristina Gifft, DO; Cliff Chen, MD; Jad Omran, MD; Mohammad Eniezat, MD; and Michael Reardon, MD
26:08
October 18, 2021
The King and I: Season2, Episode 15 | Impact of COVID-19 on Medical Conferences
Ron Waksman, Spencer B. King, III
28:53
October 12, 2021
The King and I: Season2, Episode 14 | Vaccination Mandate and Third Vaccine
Ron Waksman, Spencer B. King, III
37:58
October 07, 2021
CRM Journal Club | Implications of COVID-19 on Time-Sensitive STEMI Care: A Report From a North American Epicenter
Kevin Haddad, MD, MSc; Brian J. Potter, MDCM, SM; Alexis Matteau, MD, SM; Francois Gobeil, MD; and Samer Mansour, MD
30:57
September 27, 2021
The King and I: Season2, Episode 13 | On ESC Trials and Guidelines
Ron Waksman, Spencer B. King, III
29:07
September 09, 2021
My Next Guest Is Nanette Wenger, MD
Dr. Ron Waksman’s next guest is Nanette Wenger, MD
27:39
August 26, 2021
My Next Guest is George Vetrovec, MD
Dr. Ron Waksman’s next guest is George Vetrovec, MD
18:51
August 17, 2021
The King and I: Season2, EP 11 | Should We Mandate Vaccines for All?
Ron Waksman, Spencer B. King, III
29:27
August 17, 2021
The King and I: Season2, EP 10 | Is there Cardiologist Burn Out?
Ron Waksman, Spencer B. King, III
21:52
July 26, 2021
The King and I: Season2, EP 8 - Physiology post-PCI: Will it make a difference?
Drs. Spencer King and Ron Waksman discuss whether the use of physiology after percutaneous coronary intervention makes a difference in clinical outcomes.
21:35
July 01, 2021
The King and I: Season2, EP 7 - Cardiologists as media commentators
Drs. Spencer King and Ron Waksman discuss the phenomenon of cardiologists as media commentators, including the question of whether cardiologists should comment on non-cardiology medical topics.
21:34
July 01, 2021
The King and I: Season2, EP 5 - ACC.21 Virtual: Antithrombotic Regimens and Guidelines
Drs. Ron Waksman and Spencer King continue their discussion of late-breaking trials presented at ACC.21 Virtual. This time, they focus on studies of antiplatelet regimens in patients with acute coronary syndrome and antithrombotic regimens after transcatheter aortic valve replacement. They also talk about the frequency (or lack thereof) of updates to guidelines.
20:28
July 01, 2021
The King and I: Season2, EP 4 - ACC.21 Virtual: Complete Revascularization and Physiology Studies
Drs. Ron Waksman and Spencer King discuss the results of late-breaking trials presented at ACC.21 Virtual that report on complete revascularization and physiology. They start with a conversation about when cardiology conferences might be held in person again.
27:17
July 01, 2021
The King and I: Season 2, EP 6 - Conflict of interest and Guidelines
Drs. Spencer King and Ron Waksman discuss whether authors who involved in developing guidelines should have conflicts of interest with industry. A recent article reported that 80% of European guidelines writers have conflicts. Does this bias guidelines or do these authors have more experience and insights that can strengthen these documents?
23:09
June 22, 2021
RESCUE
Dr. Paul Ridker, of Brigham and Women’s Hospital, Boston, discusses with Dr. Ron Waksman results from the RESCUE trial, which randomized patients at high atherosclerotic risk with stage 3-5 chronic kidney disease to receive ziltivekimab, a novel interleukin-6 ligand inhibitor (7.5 mg, 15 mg or 30 mg) or a placebo. The study, presented as a late-breaking trial at ACC.21 Virtual, found that ziltivekimab markedly reduced multiple biomarkers of systemic inflammation and thrombosis known to promote the atherosclerotic process as compared to placebo.
16:45
June 01, 2021
REALITY
Dr. José R. González-Juanatey, of University Hospital, Santiago de Compostela, Spain, discusses with Dr. Ron Waksman results from the REALITY trial, which randomized anemic patients presenting with myocardial infarction to a liberal strategy of red blood cell transfusion or a restrictive strategy. REALITY, which was presented as a late-breaking trial at ACC.21 Virtual, found that the restrictive strategy did not achieve non-inferiority at 1 year after treatment. This was against the pre-study hypothesis, which was that the restrictive strategy would be non-inferior and less costly compared to the liberal strategy.
14:44
June 01, 2021
NCDR LAAO Registry
Dr. Matthew Price, of Scripps Clinic, La Jolla, California, discusses with Dr. Ron Waksman 1-year clinical outcomes after transcatheter left atrial appendage occlusion (LAAO) for stroke prevention in patients with atrial fibrillation (AF). This report from the National Cardiovascular Data Registry (NCDR) LAAO Registry, which was presented as a late-breaking trial at ACC.21 Virtual, found that thromboembolic events were infrequent in patients implanted with the Watchman (Boston Scientific) LAAO device. Study investigators did recommend that clinicians should incorporate risks of bleeding and death unrelated to thromboembolism in the early post-discharge period when selecting a stroke-prevention strategy for AF patients who are unable to take long-term oral anticoagulation.
14:08
June 01, 2021
SAFE-PAD
Dr. Eric A. Secemsky, of Beth Israel Lahey Health, Boston, discusses with Dr. Ron Waksman initial results from the SAFE-PAD study, which was presented as a late-breaking trial at ACC.21 Virtual. The observational study found that among more than 160,000 Medicare beneficiaries, in the treatment of peripheral artery disease, paclitaxel-coated devices were non-inferior to non-drug-coated devices with respect to mortality.
18:36
May 26, 2021
TWILIGHT: Sex-Specific Outcomes
Dr. Birgit Vogel, of the Icahn School of Medicine at Mount Sinai, New York, discusses with Dr. Ron Waksman a study examining sex differences in the TWILIGHT trial, which compared patients at high risk of bleeding or ischemic events who received ticagrelor alone vs. those who received ticagrelor plus aspirin after both groups received 3 months of dual antiplatelet therapy post-percutaneous coronary intervention. The study, which was presented as a late-breaking trial at ACC.21 Virtual, found that women had a higher bleeding risk than men, but men and women had similar risk of ischemic events. The higher bleeding risk in women was mostly attributable to baseline differences.
23:09
May 26, 2021
ISCHEMIA: Completeness of Revascularization – Impact on Quality of Life
Dr. Kreton Mavromatis, of Emory University and Atlanta VA Medical Center, discusses with Dr. Ron Waksman an analysis of the ISCHEMIA trial evaluating quality of life for patients who underwent complete revascularization with those who underwent more conservative treatment. This analysis, which was presented as a late-breaking trial at ACC.21 Virtual, found that complete revascularization generally resulted in greater improvement in angina-related quality of life than incomplete revascularization, particularly in patients who began the study experiencing angina on a daily or weekly basis.
10:37
May 26, 2021
ADAPTABLE
Dr. William Schuyler Jones, of the Duke Clinical Research Institute, Durham, North Carolina, discusses the ADAPTABLE trial with Dr. Ron Waksman. The study, which was presented as a late-breaking trial at ACC.21 Virtual, found no difference in a composite outcome of death, myocardial infarction or stroke between patients assigned to a low dose (81 mg) vs. a high dose (325 mg) of aspirin with a median 26-month follow-up. Of interest was that patients were recruited and randomized remotely, with no in-person study visits, which helped the investigators recruit 15,000 patients during the COVID-19-related restrictions on travel and office visits.
19:23
May 25, 2021
WASE COVID Study: Human vs. Machine-Learning Echo Analysis
Dr. Federico Asch of MedStar Washington Hospital Center discusses with Dr. Ron Waksman a study comparing the ability of human and artificial intelligence (AI) echocardiography analysis to predict outcomes in acute COVID-19 patients. The study, which was presented as a late-breaking trial at ACC.21 Virtual, found that AI-based analyses of left ventricular ejection fraction and left ventricular longitudinal strain showed a significant decrease in variance and accurately predicted in-hospital and follow-up mortality and follow-up mortality.
17:14
May 25, 2021
ISCHEMIA: Completeness of Revascularization – Impact on Clinical Outcomes
Dr. Gregg Stone of Mount Sinai Sinai Health System, New York, discusses with Dr. Ron Waksman an analysis of the ISCHEMIA trial comparing clinical outcomes of patients who underwent complete revascularization with those who underwent more conservative treatment. This analysis, which was presented as a late-breaking trial at ACC.21 Virtual, found that complete revascularization generally resulted in improved outcomes.
16:22
May 25, 2021
EBC MAIN
Dr. David Hildick-Smith, of the Sussex Cardiac Centre, UK, discusses the results of the EBC MAIN study with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, suggests no difference in 1-year clinical outcomes of a planned single-stent versus upfront two-stent strategy for true bifurcation distal left main disease.
10:34
May 21, 2021
COOL AMI EU
Dr. Marko Noc, of University Medical Center in Slovenia, discusses the results of the COOL AMI EU pivotal trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, found longer randomization-to-balloon time and longer total ischemic time, as well as high rates of new-onset paroxysmal atrial fibrillation, for patients who received a therapeutic hypothermia device, the ZOLL Proteus Intra Vascular Temperature Management System, in patients presenting with acute ST-elevation myocardial infarction as compared to patients who did not receive the device.
12:38
May 21, 2021
HOST-EXAM
Dr. Hyo-Soo Kim, of Seoul National University Hospital, discusses the results of the HOST-EXAM trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at ACC.21 Virtual, showed that clopidogrel monotherapy in the chronic maintenance period following percutaneous coronary intervention and 6 to 18 months of dual antiplatelet therapy reduced cardiovascular risk by around 27% compared to aspirin monotherapy.
18:21
May 21, 2021
ATLANTIS
Dr. Gilles Montalescot, of Pitié-Salpêtrière Hospital in Paris, discusses the results of the ATLANTIS trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at ACC.21 Virtual, showed that the blood thinner apixaban was not superior to standard of care following transcatheter aortic valve replacement in terms of net clinical benefits but may remain useful for patients with an indication for oral anticoagulation.
12:42
May 21, 2021
TALOS-AMI
Dr. Kiyuk Chang, from Seoul St. Mary’s Hospital, discusses the results of the TALOS-AMI trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at ACC.21 Virtual, showed that de-escalating stabilized acute myocardial infarction patients from high-potency dual antiplatelet therapy with ticagrelor to a lower-potency option – clopidogrel – 30 days after percutaneous coronary intervention was safer and more effective than continuing on ticagrelor beyond 30 days.
16:01
May 21, 2021
FUTURE-II
Dr. Bo Xu, of the Chinese Academy of Medical Sciences, discusses the results of the FUTURE-II trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, showed comparable safety and efficacy between the thin-strut Chinese Firesorb bioresorbable vascular scaffold and the cobalt-chromium everolimus-eluting Xience stents
12:28
May 21, 2021
Coronary Revascularization vs. Medical Therapy Alone: Meta-Analysis
Dr. Eliano Navarese, of Nicolaus Copernicus University, Poland, discusses the results of a meta-analysis comparing coronary revascularization vs. medical therapy alone. The study, presented as a late-breaking trial at EuroPCR 2021, showed that the benefits of both approaches are additive and that their combination is needed to attain maximal and lasting prevention of adverse events.
12:11
May 21, 2021
RADIANCE-HTN TRIO
Dr. Ajay Kirtane, of Columbia University Vagelos College of Physicians and Surgeons and New York-Presbyterian/Columbia University Irving Medical Center, discusses the RADIANCE-HTN TRIO trial with Dr. Waksman. The study, presented as a late-breaking trial at ACC.21 Virtual, showed that ultrasound renal denervation, as compared with a sham procedure, reduced blood pressure at 2 months in patients with hypertension resistant to a standardized triple-combination pill.
13:28
May 21, 2021
VOYAGER PAD Update
Dr. Rupert M. Bauersachs, of Klinikum Darmstadt and University of Mainz, Germany, discusses the results of the latest update from the VOYAGER PAD trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at ACC.21 Virtual, showed that rivaroxaban significantly reduced the otherwise high total event burden for peripheral artery disease patients undergoing lower-extremity revascularization by 14%.
14:31
May 21, 2021
Evinacumab to treat Severe Hypertriglyceridemia
Dr. Robert S. Rosenson of Mount Sinai Health System discusses with Dr. Ron Waksman the results of study into the first 12-week treatment period with evinacumab of patients with severe hypertriglyceridemia. The study, presented as a late-breaking trial at ACC.21 Virtual, showed triglyceride patients of around 80%  in patients with minimal mutations in lipoprotein lipase, while those with more mutations had essentially no benefit.
10:33
May 21, 2021
STRENGTH Post Hoc Analysis
Dr. Steven E. Nissen of Cleveland Clinic discusses the results of a post hoc analysis of data from the STRENGTH trial with Dr. Ron Waksman. The analysis, presented as a late-breaking trial at ACC.21 Virtual, showed no association of benefit or harm with the use of high-dose omega-3 fatty acids in patients at high cardiovascular risk.
12:44
May 21, 2021
The King and I: Season 2, EP 3 - Should physicians make public statements on controversial issues?
In this episode, Drs. Ron Waksman and Spencer King discuss whether physicians should express their views on controversial domestic and international issues. With the caveat that younger physicians may have different views, Dr. King explains why he feels no qualms about expressing his opinion on health issues such as whether to get vaccinated, but he says it is best not to wade into non-health controversies.
20:55
May 18, 2021
The King and I: Season 2, EP 2 - How to get everyone vaccinated?
Drs. Ron Waksman and Spencer King discuss how to get everyone to take the COVID-19 vaccine now that demand is starting to slow down.
17:52
May 14, 2021
The King and I: Season 2, EP 1 - Patient shared decision making
Drs. Ron Waksman and Spencer King kick off the second season of “The King and I” with a discussion of shared decision making between patients and physicians. They ponder this question: How can shared decision making be attained when patients rely on physicians for the information they need to make the decision?
13:31
May 14, 2021
The King and I: Season2, Episode 1 | Patient shared decision making
Ron Waksman and Spencer B. King, III
13:31
May 10, 2021
My Next Guest is Steven Bailey, MD
Dr. Ron Waksman’s next guest is Steven Bailey, MD, the chairman of internal medicine at LSU Health in Shreveport, Louisiana, and editor-in-chief of Catheterization and Cardiovascular Interventions, the official journal of the Society for Cardiovascular Angiography and Interventions. Their wide-ranging discussion includes Dr. Bailey’s research interests, such as the association of NADPH oxidases (NOX) inflammatory pathways with atherosclerosis and renal function, the effects of COVID-19 on pulmonary endothelial and mesenchymal cells, and his work on the development of innovative treatments and technologies in the field of interventional cardiology.
20:02
April 09, 2021
My Next Guest is Tim Fischell, MD
Dr. Ron Waksman’s next guest is Tim Fischell, MD, a professor of medicine at Michigan State University and the director of cardiovascular research and the interventional cardiology fellowship program at the Ascension Borgess Hospital Heart Institute in Kalamazoo, Michigan. They discuss innovation in the field. Innovation is a particular area of interest for Dr. Fischell, who holds a number of patents.
16:46
April 09, 2021
My Next Guest is Aaron Kaplan, MD
Dr. Ron Waksman’s next guest is Dr. Aaron Kaplan, of Dart-Hitchcock Medical Center. They discuss Dr. Kaplan’s accomplishments in the field of interventional cardiology, including his go-to solution to problems he encounters during procedures: inventing devices.
27:48
April 09, 2021
My Next Guest Is... Gary Mintz, MD
Dr. Ron Waksman’s next guest is Dr. Gary Mintz, a consulting editor for Cardiovascular Revascularization Medicine. They discuss Dr. Mintz’s pioneering work in cardiovascular imaging.
32:27
February 09, 2021
My Next Guest Is...Gerald Dorros, MD
Dr. Ron Waksman’s next guest is Dr. Gerald Dorros, one of the pioneers of interventional cardiology. Dr. Dorros recalls the field’s early days, in the late 1970s, when there were no such devices as arterial sheaths, which required clinicians to adapt with existing equipment that was not designed to open the coronary arteries. He also discusses how the field has changed over the years. Watch the episode on CRTonline
21:07
December 30, 2020
My Next Guest Is...Marco Zimarino, MD
Dr. Ron Waksman’s next guest is Dr. Marco Zimarino, of the University of the Chieti-Pescara, Italy. Drs. Waksman and Zimarino discuss the fierce competition that characterizes cardiology in Italy and a recent paper about transfusion after transcatheter aortic valve replacement, on which Dr. Zimarino was first author, which was published in Circulation: Cardiovascular Interventions. Watch the episode on CRTonline
21:23
December 14, 2020
The King and I - Epsiode 15: Legacy of Spencer B. King, III
Dr. Spencer B. King, III, a pioneer in the field of interventional cardiology, discusses his legacy in an interview with Dr. Ron Waksman. Dr. King recalls his efforts to recruit Dr. Andreas Gruentzig, who performed the first successful coronary balloon angioplasty, to move to Emory University from Zurich, Switzerland. Dr. King also discusses the development of interventional cardiology into a mature field in its own right, along with the roles he and his colleagues played in that progression. 
29:35
December 04, 2020
AHA 2020 Interview: The STRENGTH Trial
Drs. Ron Waksman and Michael Lincoff discuss the STRENGTH trial, which was presented at the American Heart Association Scientific Sessions 2020 virtual conference. This trial showed no significant reduction in risk of cardiac events with a new fish oil medication, omega-3 carboxylic acids (CA) as compared to a corn-oil placebo in those patients with existing heart disease or who were at high risk of heart disease due to other medical conditions.
18:11
November 30, 2020
AHA 2020 Interview: Subgroup Analysis of the THALES Study
Drs. Ron Waksman and Pierre Amarenco discuss a subgroup analysis of the THALES study, which was presented at the American Heart Association Scientific Sessions 2020 virtual conference. This analysis showed that ticagrelor added to aspirin reduced the 30-day risk of recurrent stroke by 27% in transient ischemic attack (TIA) and minor ischemic stroke patients with ipsilateral atherosclerotic stenosis of cervicocranial vasculature.
21:04
November 30, 2020
My Next Guest Is... | Discussing Peri-Procedural MI on Outcomes After Revascularization
Dr. Ron Waksman’s guest this time is Professor Patrick W. Serruys, MD, PhD, of National University of Ireland Galway. Professor Serruys discusses his latest work, including studies concerning FFR-CT and periprocedural MI.
35:08
October 12, 2020
The King and I - Episode 14: Discussing Walter Reed
Walter Reed National Medical Center in Bethesda, Maryland, has been in the news quite a bit during the last week. In this episode, Dr. Spencer King discusses his time working at what he calls the “real Walter Reed,” when it was known as Walter Reed Army Medical Center in Washington, D.C. When the D.C. facility closed, the name moved to what was previously known as the National Naval Medical Center in Bethesda. Drs. King and Ron Waksman also discuss the controversy surrounding the statements concerning President Donald Trump’s status after he became a COVID-19 patient.
23:22
October 07, 2020
My Next Guest Is... | Beyond Intervention: Personalized Vascular Care Through Technological Innovation
Dr. Ron Waksman kicks off a new interview series, “My Next Guest Is …” His first guest is Dr. Nick West, Chief Medical Officer of Abbott Vascular. They discuss personalized medicine and recent research and trends in interventional cardiology.
28:10
October 01, 2020
The King and I - Episode 13: Discussing In-Stent Restenosis
A paper published in the Journal of the American College of Cardiology reports that about 10% of the PCIs performed in the U.S. between 2009 and 2017 were for in-stent restenosis. Drs. Ron Waksman and Spencer King discuss this paper, and the overall topic of treating ISR, in this episode of “The King and I.” Dr. King points out that ISR has been a known issue with PCI since the days of interventional cardiology pioneer Dr. Andreas Gruentzig. Watch on CRTonline
25:19
September 25, 2020
COVID-19 Focused Discussions: Histopathology of COVID -19 Myocarditis - One on One with Dr. Aloke Finn
In our latest COVID-19 Focused Discussion, Drs. Aloke Finn and Ron Waksman discuss STEMI and microthrombi in COVID-19 patients. In a paper recently published in Circulation, Dr. Finn and co-authors presented the case of a 43-year-old woman who died of COVID-19 at a hospital during the height of the initial surge of infections in Italy. This case showed the potential for microvascular thrombi to cause acute myocardial infarction in the setting of COVID-19, showing a novel mechanism by which the disease can cause cardiac injury. Watch on CRTonline
16:10
September 17, 2020
COVID-19 Focused Discussions: COVID-19 Registry at Yale - One on One with Dr. Manan Pareek
In the latest of Dr. Ron Waksman’s COVID-19 Focused Discussions, Dr. Manan Pareek discusses Yale University’s COVID-19 registry. While the registry’s focus is cardiovascular variables, Yale has collected data on a number of non-cardiovascular factors and outcomes as well. Data on the first 485 patients were presented at the European Society of Cardiology (ESC) 2020 virtual congress. The data show that these patients had a high burden of cardiovascular risk factors, including diabetes, obesity, hypertension and hyperlipidemia, and that nearly half had a history of cardiovascular disease.
24:45
September 16, 2020
The King and I - Episode 12: Freedom Is Not an Entitlement When It Comes to Healthcare
Drs. Ron Waksman and Spencer King discuss Dr. King’s latest monthly column for Cardiovascular Revascularization Medicine (CRM), titled “Freedom Is Not Entitlement.” In this column, which is scheduled to appear in the December issue of CRM, Dr. King says that “freedom” to not wear a mask in public during the COVID-19 pandemic actually infringes on the freedom of others to not be infected with the novel coronavirus. Dr. Waksman is the Editor-in-Chief of CRM, and Dr. King is Editor-at-Large. Watch on CRTonline
20:50
September 15, 2020
New STEMI ESC Guidelines
Drs. Ron Waksman and Holger Thiele discuss new guidelines for treating patients with ST-elevation myocardial infarction (STEMI), which were released during the European Society of Cardiology 2020 virtual congress. Among the changes in guidelines they discuss are how to use high-sensitivity cardiac troponin, elimination of one risk category (moderate) for patients with non-ST-elevation myocardial infarction (NSTEMI), and the role of electrocardiograms in stratifying risk level. Watch the interview on CRTonline
24:09
September 11, 2020
Treatment for Patients with Stable Ischemic Heart Disease and Heart Failure
Drs. Ron Waksman and Renato Lopes discuss the results of a study presented as a late-breaking trial at the European Society of Cardiology 2020 virtual congress. This study examined whether medical therapy or more or an invasive strategy was better for patients with intermediate heart failure (ejection fraction of 35% to 45%) and stable ischemic heart disease. When compared with patients with ischemia but without heart failure, stable ischemic patients with heart failure saw a benefit from invasive intervention. Watch the interview on CRTonline
10:58
September 11, 2020
BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19 with Dr. Renato Lopes
Drs. Ron Waksman and Renato Lopes discuss the results of the BRACE CORONA study, which was presented as a late-breaking trial at the European Society of Cardiology virtual congress. The study examined the difference between continuing or suspending ACE inhibitors and angiotensin receptor blockers in COVID-19 patients. Dr. Lopes provides insights into the top-line findings, which is that there were no significant differences between the two treatment regimens. Watch the interview on CRTonline
12:29
September 11, 2020
The King and I - Episode 11: Role of Colchicine in CAD
Drs. Ron Waksman and Spencer King discuss these and whether now, with two trials indicating that colchicine may be effective in treating CAD being released within the last year, cardiologists should start using this medication more widely. One question they ponder: Where does colchicine fit into the armamentarium of therapies, including statins, PCSK9 inhibitors, fish oil, and Lp(a)? Another question that those creating treatment guidelines should consider: What patients benefit the most from which therapies? Watch on CRTonline
20:37
September 04, 2020
LoDoCo2: Low-Dose Colchicine in Coronary Disease Trial Discussion
Drs. Ron and Waksman and Aernoud Fiolet discuss the LoDoCo 2 trial, which was presented at the European Society of Cardiology 2020 virtual congress on Aug. 31, 2020. The study found that low-dose colchicine reduces the risk of cardiovascular events in patients with chronic coronary disease. The European Society of Cardiology 2020 virtual congress included three studies that examined the role of colchicine, a gout medication, in treating coronary artery disease. Watch the interview
17:32
September 02, 2020
The King and I - Episode 10: Taking on Complete Revascularization
When a patient suffers a STEMI, should clinicians revascularize only the culprit lesion or any lesions that the patient has? This has been an ongoing debate for some time in the field. Dr. Spencer King says complete revascularization is a good goal, but it is not necessarily critical – or better for the patient – that all lesions be revascularized immediately after treating the infarct-related vessel. Watch on CRTonline
20:15
August 26, 2020
The King and I - Episode 9: Taking on Periprocedural MI
The latest angle in the ongoing heated debate around the EXCEL trial, comparing percutaneous coronary intervention (PCI) and coronary artery bypass grafting for revascularization of the left main coronary artery, concerns how important a role periprocedural myocardial infarction (MI) should play in this comparison. Drs. Spencer King and Ron Waksman take on this topic and say, in part, that perhaps the endpoints in these studies of PCI and surgery need to be re-examined. Watch on CRTonline
18:19
August 26, 2020
COVID-19 Focused Discussions: Anticoagulation in Patients with Covid-19: One-on-One with Dominick Angiolillo
Drs. Ron Waksman and Dominick Angiolillo discuss anticoagulation in patients with COVID-19. Listen in on this riveting one on one discussion.  Watch in the interview on CRTonline
28:11
August 20, 2020
The King and I - Episode 8: Tips and Tricks to Submitting to an Academic Journal
Drs. Ron Waksman and Spencer King discuss the contents of Dr. King's last editorial published in the Cardiovascular Revascularization Medicine. In doing so, they also offer tips and tricks to submitting to an academic journal. Watch the video on CRTonline
27:60
August 07, 2020
The King and I - Episode 7: Physicians Taking Care of VIP Patients
Hear Drs. Ron Waksman and Spencer King, III as they discuss physicians taking care of VIP patients. You'll all get an insight on Spencer King's experience with actress Jessica Tandy.  Watch the video on CRTonline
18:22
August 05, 2020
The King and I - Episode 6: Remembering John Lewis
We are deeply saddened by the loss of a great civil rights icon and politician, John Robert Lewis. Watch or listen to Dr. Spencer King describe his personal relationship with John Lewis, and let's continue the conversation in his remembrance. Watch the video on CRTonline
21:46
July 31, 2020
COVID-19 Focused Discussions: One-on-One with Dan Chertow: NIH View and Research on COVID -19
Dr. Ron Waksman interviews Dr. Daniel S. Chertow, an investigator with the Emerging Pathogens Section of the NIH Clinical Center, about the state of research into COVID-19 pathophysiology and treatment. Watch the interview videos on CRTonline
40:47
July 27, 2020
COVID-19 Focused Discussions: On the Frontline of COVID-19
Several months into the COVID-19 pandemic, Dr. Ben Kenigsberg of MedStar Washington Hospital Center discusses how the intensive care unit has functioned and adapted to a stream of COVID-19 patients. During an interview with Dr. Ron Waksman, Dr. Kenigsberg also discusses the state of COVID-19 treatments, including hydroxychloroquine and remdesivir, and how patient protocols changed as the pandemic has continued. Watch the interview videos on CRTonline
21:08
July 21, 2020
The King & I - Episode 5: In Person vs. Virtual Meetings
As virtual meetings become the norm during the COVID-19 pandemic, Drs. Ron Waksman and Spencer King discuss the advantages and disadvantages of virtual conferences as opposed to in-person gatherings. Dr. King says the presentations are fine virtually or in person, but the traditional meetings in conference centers and hotels have the opportunity for interaction and networking that is lost when everything goes online. Watch the video on CRTonline
29:48
July 17, 2020
COVID-19 Focused Discussions: My Experience as a Commentator during COVID-19
Dr. Jonathan S. Reiner has been a commentator for varies news outlets during the COVID-19 pandemic. Hear him one on one with Dr. Ron Waksman giving a detailed insight on his experience.  Watch this video on CRTonline
37:18
July 16, 2020
COVID-19 Focused Discussions: One-on-One with Dr. Azeem Latib
Dr. Azeem Latib of Montefiore Medical Center in the Bronx, New York, recalls when COVID-19 came to his center. In an interview with Dr. Waksman, Dr. Latib discusses how his hospital prepared and when he, and eventually a number of his colleagues and his own family members, became infected with the novel coronavirus in spring 2020. Watch the interview video on CRTonline
25:10
July 16, 2020
The King & I - Episode 4: The Politics of COVID-19
Drs. Spencer King and Ron Waksman discuss the politics of the COVID-19 pandemic. Dr. King postulates that part of it is a human need to blame somebody for a major problem such as what the outbreak has become, whether the blame is China, President Trump or even Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who has been criticized by both Democrats and Republicans. Dr. Waksman notes that the pandemic is taking place with the backdrop of a hotly contested U.S. presidential election.  Watch this episode on CRTonline
21:16
July 15, 2020
The King & I - Episode 3: Social Injustice and Racial Disparities
Drs. Ron Waksman and Spencer King discuss the social justice protests that have swept the U.S. and the world. Dr. King remembers growing up in the Jim Crow South and the fact that even a century after the Civil War, integrating society continued to be a struggle. He expresses hope that the current movement will result in lasting change because of its magnitude and the involvement of politicians to a degree not seen after similar protests in recent years. Drs. King and Waksman also note that more journal articles concerning racial disparities in medicine have been published, which Dr. King says is a natural response of researchers trying to incorporate current events into their manuscripts. Watch this episode on CRTonline
18:14
July 14, 2020
The King & I - Episode 2: Demonstration of Anticoagulation Regimen
Drs. Ron Waksman and Spencer King discuss a recent editorial that Dr. King wrote for Cardiovascular Revascularization Medicine concerning the many iterations of anticoagulation regimens. Dr. King notes the conflicting signals from different trials examining antithrombotic therapy after PCI in patients presenting with different conditions. One key point is the search for the right balance between bleeding and thrombotic risk, but does this mean lower doses of antithrombotic agents, a shorter duration of antiplatelet therapy, or something else? The struggle is real. Watch this episode on CRTonline
15:60
July 14, 2020
The King & I - Episode 1: Fellows and Fellowship
CRT 2021 Course Chairman Ron Waksman, MD, kicks off a new series of video discussions with Spencer B. King III, MD, professor emeritus at Emory University, called “The King and I.” Dr. King is the Editor-at-Large of Cardiovascular Revascularization Medicine, the official peer-reviewed journal of CRT Meeting, and he is an interventional cardiology pioneer. He writes a monthly column, “The Last Word with Spencer King,” for the journal. The first episode of “The King and I” was recorded July 1, which is the first day of the new academic year, so Drs. King and Waksman discuss the state of interventional cardiology fellowships today, including effects of the COVID-19 pandemic. Watch this episode on CRTonline
15:53
July 13, 2020